S-1

Company

Viking Therapeutics, Inc.

Filed

December 20, 2017

Accession Number

0001564590-17-025157

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →